Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response

Diabetes insipidus is a disease in which large volumes of dilute urine (polyuria) are excreted due to vasopressin (AVP) deficiency [central diabetes insipidus (CDI)] or to AVP resistance (nephrogenic diabetes insipidus). In the majority of patients, the occurrence of CDI is related to the destructio...

Full description

Bibliographic Details
Main Authors: Giuseppe Murdaca, Rodolfo Russo, Francesca Spanò, Diego Ferone, Manuela Albertelli, Angelo Schenone, Miriam Contatore, Andrea Guastalla, Annamaria De Bellis, Giacomo Garibotto, Francesco Puppo
Format: Article
Language:English
Published: Brazilian Society of Endocrinology and Metabolism 2015-08-01
Series:Archives of Endocrinology and Metabolism
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972015000600554&lng=en&tlng=en
_version_ 1830307072976093184
author Giuseppe Murdaca
Rodolfo Russo
Francesca Spanò
Diego Ferone
Manuela Albertelli
Angelo Schenone
Miriam Contatore
Andrea Guastalla
Annamaria De Bellis
Giacomo Garibotto
Francesco Puppo
author_facet Giuseppe Murdaca
Rodolfo Russo
Francesca Spanò
Diego Ferone
Manuela Albertelli
Angelo Schenone
Miriam Contatore
Andrea Guastalla
Annamaria De Bellis
Giacomo Garibotto
Francesco Puppo
author_sort Giuseppe Murdaca
collection DOAJ
description Diabetes insipidus is a disease in which large volumes of dilute urine (polyuria) are excreted due to vasopressin (AVP) deficiency [central diabetes insipidus (CDI)] or to AVP resistance (nephrogenic diabetes insipidus). In the majority of patients, the occurrence of CDI is related to the destruction or degeneration of neurons of the hypothalamic supraoptic and paraventricular nuclei. The most common and well recognized causes include local inflammatory or autoimmune diseases, vascular disorders, Langerhans cell histiocytosis (LCH), sarcoidosis, tumors such as germinoma/craniopharyngioma or metastases, traumatic brain injuries, intracranial surgery, and midline cerebral and cranial malformations. Here we have the opportunity to describe an unusual case of female patient who developed autoimmune CDI following ureaplasma urealyticum infection and to review the literature on this uncommon feature. Moreover, we also discussed the potential mechanisms by which ureaplasma urealyticum might favor the development of autoimmune CDI.
first_indexed 2024-12-19T10:25:00Z
format Article
id doaj.art-9232700d6ae74bff958b08ec6eaa1bcd
institution Directory Open Access Journal
issn 2359-4292
language English
last_indexed 2024-12-19T10:25:00Z
publishDate 2015-08-01
publisher Brazilian Society of Endocrinology and Metabolism
record_format Article
series Archives of Endocrinology and Metabolism
spelling doaj.art-9232700d6ae74bff958b08ec6eaa1bcd2022-12-21T20:25:56ZengBrazilian Society of Endocrinology and MetabolismArchives of Endocrinology and Metabolism2359-42922015-08-0159655455810.1590/2359-3997000000072S2359-39972015000600554Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune responseGiuseppe MurdacaRodolfo RussoFrancesca SpanòDiego FeroneManuela AlbertelliAngelo SchenoneMiriam ContatoreAndrea GuastallaAnnamaria De BellisGiacomo GaribottoFrancesco PuppoDiabetes insipidus is a disease in which large volumes of dilute urine (polyuria) are excreted due to vasopressin (AVP) deficiency [central diabetes insipidus (CDI)] or to AVP resistance (nephrogenic diabetes insipidus). In the majority of patients, the occurrence of CDI is related to the destruction or degeneration of neurons of the hypothalamic supraoptic and paraventricular nuclei. The most common and well recognized causes include local inflammatory or autoimmune diseases, vascular disorders, Langerhans cell histiocytosis (LCH), sarcoidosis, tumors such as germinoma/craniopharyngioma or metastases, traumatic brain injuries, intracranial surgery, and midline cerebral and cranial malformations. Here we have the opportunity to describe an unusual case of female patient who developed autoimmune CDI following ureaplasma urealyticum infection and to review the literature on this uncommon feature. Moreover, we also discussed the potential mechanisms by which ureaplasma urealyticum might favor the development of autoimmune CDI.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972015000600554&lng=en&tlng=en
spellingShingle Giuseppe Murdaca
Rodolfo Russo
Francesca Spanò
Diego Ferone
Manuela Albertelli
Angelo Schenone
Miriam Contatore
Andrea Guastalla
Annamaria De Bellis
Giacomo Garibotto
Francesco Puppo
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response
Archives of Endocrinology and Metabolism
title Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response
title_full Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response
title_fullStr Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response
title_full_unstemmed Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response
title_short Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response
title_sort autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972015000600554&lng=en&tlng=en
work_keys_str_mv AT giuseppemurdaca autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse
AT rodolforusso autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse
AT francescaspano autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse
AT diegoferone autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse
AT manuelaalbertelli autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse
AT angeloschenone autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse
AT miriamcontatore autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse
AT andreaguastalla autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse
AT annamariadebellis autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse
AT giacomogaribotto autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse
AT francescopuppo autoimmunecentraldiabetesinsipidusinapatientwithureaplasmaurealyticuminfectionandreviewonnewtriggersofimmuneresponse